Debiopharm targets FabI for Gram-bacterial infections with fabimycin
Aug. 26, 2022
In the search for novel antibacterial agents, some targets have been engaged to kill Gram-positive but not Gram-negative organisms, due to lack of accumulation of proposed agents.